These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35836734)

  • 1. Bradyarrhythmia After Remdesivir Administration in SARS-CoV-2: A Review of Literature and Meta-Analysis of Observational Studies in Epidemiology.
    Al-Jammali S; Al-Zakhari R; Sheets N; Mahtani A; Stefanishina V; Isber N
    Cardiol Res; 2022 Jun; 13(3):135-143. PubMed ID: 35836734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism.
    Filtz A; Carandina A; Fasiello A; Barbetta L; Lombardi R; Cinque F; Rizzi G; Ceriani E; Furlan L; Bellocchi C; Fracanzani AL; Hu C; Cogliati C; Canetta C; Peyvandi F; Montano N; Tobaldini E
    Intern Emerg Med; 2023 Mar; 18(2):359-366. PubMed ID: 36539604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Remdesivir in children with COVID-19: report of an Italian multicenter study.
    Romani L; Roversi M; Bernardi S; Venturini E; Garazzino S; Donà D; Krzysztofiak A; Montagnani C; Funiciello E; Calò Carducci FI; Marabotto C; Castagnola E; Salvini F; Lancella L; Lo Vecchio A; Galli L; Castelli Gattinara G;
    Ital J Pediatr; 2024 Feb; 50(1):32. PubMed ID: 38413992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir therapy for severe pediatric COVID-19 in Singapore: A single-center retrospective observational cohort study.
    Seah VXF; Ong RYL; Kam KQ; Thoon KC; Tan NWH; Li J; Nadua KD; Chong CY; Yung CF
    Health Sci Rep; 2023 Dec; 6(12):e1698. PubMed ID: 38098972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.
    Pilgram L; Appel KS; Ruethrich MM; Koll CEM; Vehreschild MJGT; de Miranda SMN; Hower M; Hellwig K; Hanses F; Wille K; Haselberger M; Spinner CD; Vom Dahl J; Hertenstein B; Westhoff T; Vehreschild JJ; Jensen BO; Stecher M
    Infection; 2023 Aug; 51(4):1033-1049. PubMed ID: 36763285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia.
    Donepudi B; Agarwal S; Thakur L
    Case Rep Crit Care; 2022; 2022():8807957. PubMed ID: 36267193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of bradyarrhythmia in patients with COVID-19: Systematic scoping review.
    Nagamine T; Randhawa S; Nishimura Y; Huang R; Leesutipornchai T; Benavente K; Yoshimura S; Zhang J; Kanitsorphan C
    Pacing Clin Electrophysiol; 2022 Apr; 45(4):556-566. PubMed ID: 35182433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir and Mortality in Patients With Coronavirus Disease 2019.
    Diaz GA; Christensen AB; Pusch T; Goulet D; Chang SC; Grunkemeier GL; McKelvey PA; Robicsek A; French T; Parsons GT; Doherty G; Laurenson C; Roper R; Hadlock J; Cover CJ; Footer B; Robinson P; Micikas M; Marfori JE; Cronenweth C; Mukkamala Y; Mackiewicz J; Rai E; Matson MD; Davila J; Rueda J; Tipton R; Algren H; Ward BC; Malkoski S; Gluckman T; Tallman GB; Arguinchona H; Hammond TC; Standaert S; Christensen J; Echaiz JF; Choi R; McClung D; Pacifico A; Fee M; Sarafian F; Berrington WR; Goldman JD
    Clin Infect Dis; 2022 May; 74(10):1812-1820. PubMed ID: 34409431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Remdesivir use with bradycardia: A systematic review and meta-analysis.
    Ishisaka Y; Aikawa T; Malik A; Kampaktsis PN; Briasoulis A; Kuno T
    J Med Virol; 2023 Aug; 95(8):e29018. PubMed ID: 37539782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.
    Hajimoradi M; Sharif Kashani B; Dastan F; Aghdasi S; Abedini A; Naghashzadeh F; Mohamadifar A; Keshmiri MS; Noorali S; Lookzadeh S; Alizadeh N; Siri MA; Tavasolpanahi M; Abdolmohammadi Y; Shafaghi M; Rouhani ZS; Shafaghi S
    Front Pharmacol; 2022; 13():1107198. PubMed ID: 36733376
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study.
    Khalil A; Mohamed A; Hassan M; Magboul S; Ali H; Elmasoudi AS; Ellithy K; Qusad M; Alhothi A; Al Maslamani E; Al Amri M; Soliman A
    Ther Clin Risk Manag; 2023; 19():949-958. PubMed ID: 38023628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series.
    Lee C; Ahn MY; Byeon K; Choi JP; Hahm C; Kim H; Kim S; Kim TH; Oh J; Oh DH
    Infect Chemother; 2020 Sep; 52(3):369-380. PubMed ID: 32757500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19.
    Li J; Zhang K; Wu D; Ren L; Chu X; Qin C; Han X; Hang T; Xu Y; Yang L; Yin L
    Asian J Pharm Sci; 2021 Nov; 16(6):772-783. PubMed ID: 34703490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review.
    Davoudi-Monfared E; Ahmadi A; Karimpour-Razkenari E; Shahrami B; Najmeddin F; Mojtahedzadeh M
    Am J Ther; 2022 Sep-Oct 01; 29(5):e520-e533. PubMed ID: 35984955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study.
    Spagnuolo V; Voarino M; Tonelli M; Galli L; Poli A; Bruzzesi E; Racca S; Clementi N; Oltolini C; Tresoldi M; Rovere Querini P; Dagna L; Zangrillo A; Ciceri F; Clementi M; Castagna A;
    Drug Des Devel Ther; 2022; 16():3645-3654. PubMed ID: 36268521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study.
    Schulz A; Huynh N; Heger M; Bakir M
    Mol Cell Pediatr; 2024 Feb; 11(1):2. PubMed ID: 38381231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
    Pruijssers AJ; George AS; Schäfer A; Leist SR; Gralinksi LE; Dinnon KH; Yount BL; Agostini ML; Stevens LJ; Chappell JD; Lu X; Hughes TM; Gully K; Martinez DR; Brown AJ; Graham RL; Perry JK; Du Pont V; Pitts J; Ma B; Babusis D; Murakami E; Feng JY; Bilello JP; Porter DP; Cihlar T; Baric RS; Denison MR; Sheahan TP
    Cell Rep; 2020 Jul; 32(3):107940. PubMed ID: 32668216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.
    Tchesnokov EP; Gordon CJ; Woolner E; Kocinkova D; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Nov; 295(47):16156-16165. PubMed ID: 32967965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological and sick sinus syndrome effects of Remdesivir challenge in guinea-pig hearts.
    Li S; Yue L; Xie Y; Zhang H
    Front Physiol; 2024; 15():1436727. PubMed ID: 39193439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.